AEHR TEST SYSTEMS·4

Jul 19, 4:03 PM ET

SPINK KENNETH B. 4

4 · AEHR TEST SYSTEMS · Filed Jul 19, 2023

Insider Transaction Report

Form 4
Period: 2023-07-17
SPINK KENNETH B.
VP OF FINANCE & CFO
Transactions
  • Sale

    Common Stock

    2023-07-17$51.39/sh36,511$1,876,4790 total
  • Exercise/Conversion

    Common Stock

    2023-07-17$2.40/sh+11,511$27,62611,511 total
  • Exercise/Conversion

    Common Stock

    2023-07-17$1.64/sh+25,000$40,87536,511 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2023-07-1725,0000 total
    Exercise: $1.64From: 2019-08-16Exp: 2026-07-16Common Stock (25,000 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2023-07-1711,5110 total
    Exercise: $2.40From: 2018-09-17Exp: 2025-08-17Common Stock (11,511 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    109,866
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.25 to $51.75, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
  • [F2]The amount reported includes shares subject to unvested restricted stock units.
  • [F3]One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT